DexCom Announces Initial Public Offering

DexCom Announces Initial Public Offering

Apr 14, 2005 — San Diego –(BUSINESS WIRE) — DexCom, Inc. (NASDAQ:DXCM – News) today announced the initial public offering of 4,700,000 shares of common stock at a price of $12.00 per share. DexCom is selling all of the shares in the offering. DexCom has granted the underwriters of the offering an option to purchase up to an additional 705,000 shares at the initial public offering price to cover over-allotments, if any. The common stock will trade on the NASDAQ National Market under the symbol “DXCM.”

Piper Jaffray & Co. is the sole book-running manager for the offering. SG Cowen & Co., LLC is the co-lead manager. William Blair & Company, L.L.C. and First Albany Capital Inc. are co-managers.

A registration statement relating to these securities has been filed with, and declared effective by, the Securities and Exchange Commission. This announcement shall not constitute an offer to sell or the solicitation of an offer to buy the common stock of DexCom, nor shall there be any sale of these securities in any state or jurisdiction in which such an offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction. Copies of the final prospectus may be obtained from the offices of Piper Jaffray & Co., U.S. Bancorp Center, 800 Nicollet Mall, Suite 800, Minneapolis, MN 55402.

Contact:

DexCom, Inc.
Steve Kemper, Chief Financial Officer, 858-200-0200